Currently, there is no standardized way to tell whether an infected individual (or an individual who may become infected) will be asymptomatic or require hospitalization.
The response of the human host to any infectious agent is based primarily on proteins that circulate throughout the body and transmit information across organs and biological systems. These protein changes occur dynamically and are influenced by many factors beyond infection, including age, diet, stress, chronic conditions, medications, even genetics. Measuring thousands of protein changes in the body thus uniquely provides systemic, real-time information that reflects not only current health, but also disease trajectory, as well as the effects of therapeutic interventions.
This white paper from SomaLogic describes how the SomaScan Assay, which can detect 7,000 proteins in a sample, can be used to study COVID19 illness, prognosis, long-term effects, and potential therapies, referencing published studies that employed the platform.
Offered Free by: SomaLogic
See All Resources from: SomaLogic